6505-01-174-4988 ( NDC00182-1016-10 , 01-7013 , NDC00032-2060-10 , NDC00223-1727-02 )
NSN Information
| NSN | FSC | NIIN | Item Name | INC |
|---|---|---|---|---|
| 6505-01-174-4988 | 6505 | 011744988 | SULFASALAZINE TABLETS,USP | 3420 |
NSN Features
| MRC | Parameter | Characteristics |
|---|---|---|
| CQCT | PRIMARY CONTAINER TYPE | BOTTLE |
| CRLK | PRIMARY CONTAINER CONTENT QUANTITY | 1000.000 TABLETS |
| AKJA | ACTIVE MEDICAMENT MEDICINAL STRENGTH | 500.000 MILLIGRAMS SULFASALAZINE ACTIVE INGREDIENT |
Manufacturing Part Numbers (SKUs)
| Part SKU | Cage | Status | RNVC | RNCC | SADC | DAC | RNAAC |
|---|---|---|---|---|---|---|---|
| NDC00182-1016-10 | 63488 | A | 2 | 3 | 6 | 54 | |
| 01-7013 | 63488 | A | 2 | 3 | 6 | 54 | |
| NDC00032-2060-10 | 09779 | A | 2 | 3 | 6 | 54 | |
| NDC00223-1727-02 | 21016 | A | 2 | 3 | 6 | 54 |
Manufacturers
| Part SKU | Cage | Manufacturer | Type | Status |
|---|---|---|---|---|
| NDC00182-1016-10 | 63488 | GOLDLINE LABORATORIES INC. | A | A |
| 01-7013 | 63488 | GOLDLINE LABORATORIES INC. | A | A |
| NDC00032-2060-10 | 09779 | SOLVAY PHARMACEUTICALS INC. | A | A |
| NDC00223-1727-02 | 21016 | CONSOLIDATED MIDLAND CORP | A | A |
FLIS Identification
| PMIC | ADPE Code | CRITL Code | DEMIL Code | DEMIL INTG | NIIN Asgt | ESD | HMIC | ENAC | Schedule-B | INC |
|---|---|---|---|---|---|---|---|---|---|---|
| U | X | A | 1 | 03/20/1 | P | 3004909125 | 3420 |
FLIS Management
| MOE | REC Rep Code | Mgmt Ctl | USC | Phrase Code | Phrase Statement |
|---|---|---|---|---|---|
| VA | V | K | U/I CONTAINS 1000 TT |
Demilitarization Codes & Management
| DML | PMI | HMIC | ADP | CC | ESDC |
|---|---|---|---|---|---|
| A | U | P | X |
Miscellaneous Management
| MOE (S_A) | SOS | AAC | QUP | UI | SLC | CIIC | RC | MCC | SVC |
|---|---|---|---|---|---|---|---|---|---|
| VA | I | 0 | BT | Q | U | V |
Management Control Army
| MATCAT 1 | MATCAT 2 | MATCAT 3 | MATCAT 4 5 | ARC |
|---|
Freight
| NMFC | NMFC SUB | UFC | HMC | LTL | LCL | WCC | TCC | SHC | ADC | ACC | ASH | NMF DESC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|